Cupid Limited has informed stock exchanges about the resignation of Ms. Smeeta Bhatkal from her position as Independent Director, effective from the closure of business hours on March 2nd, 2026. The announcement was made through a regulatory filing dated March 6th, 2026, in compliance with SEBI disclosure requirements.

Resignation Details

Ms. Bhatkal, who holds Director Identification Number (DIN) 07363916, submitted her resignation citing full-time professional commitments as the primary reason for her departure. In her resignation letter, she stated that due to these commitments, she would not be able to devote sufficient time to the Board.

Board Committee Impact

With Ms. Bhatkal's resignation, she will also cease to be a member of the company's Audit Committee. This change in board composition will require the company to potentially restructure its committee arrangements to maintain compliance with corporate governance requirements.

Other Directorships

According to the disclosure, Ms. Smeeta Bhatkal currently serves as an Independent Director in Prime Securities Limited, where she also holds the position of Chairperson of the Audit Committee. The company has confirmed that Ms. Bhatkal provided assurance that there are no material reasons for her resignation other than those mentioned in her resignation letter.

Regulatory Compliance

Cupid Limited has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company submitted the required information to both BSE Limited and The National Stock Exchange of India Ltd, along with comprehensive details as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Company Background

Cupid Limited operates as a manufacturer and exporter of male condoms, female condoms, water-based lubricants, and In Vitro Diagnostics (IVD) kits. The company is headquartered in Nashik, Maharashtra, with its registered office at A-68, M.I.D.C. (Malegaon), Sinnar, Nashik.

Cupid Limited has announced the record date of March 9, 2026, for its approved 4:1 bonus share allotment, following successful regulatory approvals from both BSE Limited and National Stock Exchange of India Limited. The manufacturer and exporter of male condoms, female condoms, water-based lubricants, and In Vitro Diagnostics (IVD) kits received in-principal approvals under Regulation 28(1) of SEBI (LODR) Regulations, 2015 from BSE on February 27, 2026, and from NSE on March 2, 2026.

Bonus Share Allotment Details

The company's Board of Directors has fixed Monday, March 9, 2026, as the record date for determining shareholder eligibility for the bonus equity shares. The deemed date of allotment will be Tuesday, March 10, 2026, in accordance with SEBI Circular No. SEBI CIR/CFD/PoD/2024/122 dated September 16, 2024.

Regulatory Approvals and Compliance

The bonus share issuance follows the overwhelming shareholder approval received during the company's Extra Ordinary General Meeting held on February 24, 2026. The bonus share resolution achieved 99.99% approval with 12,73,65,000 votes in favor and only 511 votes against, demonstrating near-unanimous shareholder support.

Under the approved bonus scheme, eligible shareholders will receive 4 new fully paid-up equity shares of Re. 1/- each for every 1 existing fully paid-up equity share of Re. 1/- held as on the record date. The total allotment comprises 107,57,28,560 bonus equity shares, significantly expanding the company's equity base.

Previous EGM Success and Strategic Approvals

The bonus share allotment represents the culmination of comprehensive corporate restructuring approved during the February 24, 2026 EGM. All five resolutions presented to shareholders received requisite majority approval, including the increase in authorized capital and alteration of the Capital Clause in the Memorandum of Association.

Market Impact and Shareholder Benefits

The 4:1 bonus ratio represents a substantial reward for existing shareholders, effectively increasing their shareholding by 400% without additional investment. The bonus share allotment is expected to improve liquidity and make the stock more accessible to retail investors by reducing the per-share price proportionally.

The company communicated the record date and allotment details to both BSE Limited (Scrip Code: 530843) and National Stock Exchange of India Limited (Scrip Code: CUPID) on March 2, 2026, ensuring full regulatory compliance and transparency in the bonus share distribution process.